Social Media Ideas for Cvs Health Corp.

CVS Health Stock Still Looks Good Even If Health Cost Woes Materialize

How CVS Caremark builds the next era of pharmacy benefits

Biosimilars, transparency and AI are reshaping pharmacy benefits. Learn how CVS Caremark plans to improve affordability and make pharmacy benefits easier to navigate.

CVS Settles Justice Department Case Over Opioid Prescriptions for $315M

CVS Health has agreed to pay $315 million to resolve allegations that the pharmacy chain operator unlawfully filled medically unnecessary prescriptions for addictive opioid painkil...

CVS, DOJ reach $315M settlement in opioid prescription case

CVS Health has reached a $315 million settlement with the Department of Justice that resolves allegations the pharmacy giant knowingly filled unlawful opioid prescriptions.

CVS to pay $315M to settle opioid prescribing allegations

Prosecutors say the company filled unnecessary prescriptions that fueled the opioid epidemic. A spokesperson for CVS said the company admitted to no wrongdoing and “strongly disagr...

CVS agrees to pay $315 million to settle Justice Department case over opioid prescriptions

The settlement resolves a lawsuit brought in 2024 that accused the healthcare giant of providing massive amounts of opioids and other controlled substances "to fuel its own profits...

CVS Will Pay $315 Million To Settle Federal Opioid Case

The agreement settles a lawsuit the Justice Department filed back in 2024, claiming CVS improperly filled opioid prescriptions and billed federal health care programs.

CVS to pay $315 million settlement to resolve DOJ opioid lawsuit

CVS Pharmacy Inc. and various subsidiaries have agreed to pay $315 million to resolve a Justice Department case alleging it unlawfully dispensed medically unnecessary prescriptions...

2 Stocks That Could Capitalize on the GLP-1 Boom

They aren't the most prominent names in the GLP-1 space, but they are worth a second look.

Elevance leads UBS health benefits survey as employers brace for higher costs

CVS Agrees To Pay $315 Million Over Unlawful Controlled Substance Prescriptions – Here’s What Patients Should Know

CVS has agreed to pay $315 million to settle federal claims over how its pharmacies filled opioid prescriptions.

Centene, Harmony Biosciences lead list of undervalued healthcare stocks

The Boulder Group Arranges Sale of CVS In Indianapolis MSA

CVS agrees to a $315 million opioid settlement

CVS agrees to a $315 million opioid settlement Oct. 13, 2026 – CVS has agreed to pay $315 million to resolve federal allegations of unlawfully filling controlled-substance prescrip...

CVS to pay $315 million and implement safeguards in a legal settlement involving invalid opioid prescriptions

CVS agreed to pay $315 million and for illegally filling unlawful opioid prescriptions and submitting false claims to federal healthcare programs.

CVS settles lawsuit over opioid dispensing for $315 million

CVS reached a $315 million settlement Tuesday to resolve allegations that it illegally filled prescriptions for opioids and other controlled substances for over a decade and then s...

CVS Hit with $315 Million Opioid Settlement — What LGBTQ+ and Cancer Patients Need to Know

By: Paul Goldberg – Senior Correspondent | LGBT Politics USA WASHINGTON, D.C. — (October 17, 2026) — CVS Pharmacy has agreed to pay $315 million to settle federal allegations invol...

Froedtert sues CVS over $18M in 340B drug discounts

Froedtert Hospital is suing CVS Health, alleging CVS improperly kept $18 million in reimbursements from the federal 340B drug discount program. The post Froedtert sues CVS over $18...

AbbVie vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?

AbbVie generates $17.8 billion in annual free cash flow but faces patent cliffs, while Vertex boasts a 33% net margin with concentrated cystic fibrosis exposure.

CVS Pharmacy to Pay Out $315M for Illegally Filled Opioid Scripts and Bogus Claims to Federal Govt.

Best Healthcare PR Campaigns of 2026

CVS walked away from $2B in tobacco revenue and became a healthcare PR story. Theranos built a $9B valuation on marketing alone before it collapsed. Seven healthcare PR campaigns w...

Online CVS Shoppers Might Be Able to Cash In on a $20.5 Million Settlement

The pharmacy chain denies wrongdoing, but is settling anyway.

Viatris: Improved Confidence Drives M&A Action Again

Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPH

Vanguard's broader healthcare portfolio charges less and yields more, but State Street's pharma-focused fund has delivered stronger recent gains despite higher volatility.